Related Experiment Video

Updated: Apr 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

922

The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy

Elzbieta Gocek1, George P Studzinski2

  • 1Faculty of Biotechnology, University of Wroclaw, Joliot-Curie 14a, Wroclaw 50-383, Poland. elzbieta.gocek@uni.wroc.pl.

Journal of Clinical Medicine
|August 5, 2015
PubMed

Insights

Innovative treatments targeting cell signaling pathways like MAPK and JAK/STAT, particularly with vitamin D derivatives, show promise for acute myeloid leukemia (AML). Further research is needed to confirm clinical utility.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Standard acute myeloid leukemia (AML) treatments have limited efficacy, necessitating novel therapeutic strategies.
  • Targeting cell signaling pathways crucial for cancer cell growth and survival offers a promising avenue for developing less toxic cancer drugs.
  • The MAPK, PI3K/AKT/FOXO, and JAK/STAT signaling pathways are key regulators of cell proliferation and survival in cancer.

Purpose of the Study:

  • To review recent advancements in targeting cell signaling pathways for AML treatment.
  • To highlight the role of vitamin D and its derivatives in modulating these pathways and their anti-cancer properties.
  • To discuss the interplay of microRNAs, transcriptomics, and vitamin D in cancer therapy.

Main Methods:

  • Literature review of studies focusing on MAPK, PI3K/AKT/FOXO, and JAK/STAT signaling pathways in cancer.
  • Analysis of research investigating the anti-cancer effects of vitamin D and its derivatives.
  • Exploration of the role of microRNAs and transcriptomic data in vitamin D's biological activity.

Main Results:

  • Vitamin D and its derivatives demonstrate anti-cancer properties by influencing key signaling pathways.
  • Activated vitamin D regulates microRNAs, suggesting a role in post-transcriptional gene regulation in cancer.
  • Emerging transcriptomic data and combination therapies may potentiate vitamin D's anti-cancer effects.

Conclusions:

  • Targeting cell signaling pathways, especially with vitamin D, represents a promising strategy for novel AML therapies.
  • Further clinical studies are essential to validate the therapeutic potential of vitamin D in cancer treatment.
  • The integration of microRNA and transcriptomic data may offer new insights into vitamin D's mechanisms of action.
Keywords:
1,25-dihydroxyvitamin D3acute myeloid leukemiadifferentiationmitogen-activated kinasestargeted therapy

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K